GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instituto Rosenbusch SA (BUE:ROSE) » Definitions » Piotroski F-Score

Instituto Rosenbusch (BUE:ROSE) Piotroski F-Score : 6 (As of May. 29, 2024)


View and export this data going back to . Start your Free Trial

What is Instituto Rosenbusch Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Instituto Rosenbusch has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Instituto Rosenbusch's Piotroski F-Score or its related term are showing as below:

BUE:ROSE' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 6   Max: 8
Current: 6

During the past 13 years, the highest Piotroski F-Score of Instituto Rosenbusch was 8. The lowest was 2. And the median was 6.


Instituto Rosenbusch Piotroski F-Score Historical Data

The historical data trend for Instituto Rosenbusch's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instituto Rosenbusch Piotroski F-Score Chart

Instituto Rosenbusch Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 7.00 5.00 5.00 7.00

Instituto Rosenbusch Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 6.00 7.00 7.00 6.00

Competitive Comparison of Instituto Rosenbusch's Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Instituto Rosenbusch's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Instituto Rosenbusch's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instituto Rosenbusch's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Instituto Rosenbusch's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was 4.15 + 259.309 + 417.64 + 317.734 = ARS999 Mil.
Cash Flow from Operations was 9.222 + 50.27 + 59.826 + 545.826 = ARS665 Mil.
Revenue was -342.824 + 869.952 + 2688.119 + 1959.616 = ARS5,175 Mil.
Gross Profit was -65.727 + 95.651 + 894.392 + 1370.981 = ARS2,295 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was
(1652.525 + 1905.597 + 2709.267 + 5042.761 + 6565.284) / 5 = ARS3575.0868 Mil.
Total Assets at the begining of this year (Mar23) was ARS1,653 Mil.
Long-Term Debt & Capital Lease Obligation was ARS562 Mil.
Total Current Assets was ARS5,155 Mil.
Total Current Liabilities was ARS2,104 Mil.
Net Income was 3.934 + -20.794 + -79.44 + -118.159 = ARS-214 Mil.

Revenue was 248.413 + 232.837 + 2247.425 + 1312.808 = ARS4,041 Mil.
Gross Profit was 119.18 + 88.652 + 1113.727 + 411.146 = ARS1,733 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was
(848.619 + 970.219 + 1209.15 + 4197.751 + 1652.525) / 5 = ARS1775.6528 Mil.
Total Assets at the begining of last year (Mar22) was ARS849 Mil.
Long-Term Debt & Capital Lease Obligation was ARS206 Mil.
Total Current Assets was ARS1,261 Mil.
Total Current Liabilities was ARS863 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Instituto Rosenbusch's current Net Income (TTM) was 999. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Instituto Rosenbusch's current Cash Flow from Operations (TTM) was 665. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=998.833/1652.525
=0.60442837

ROA (Last Year)=Net Income/Total Assets (Mar22)
=-214.459/848.619
=-0.25271529

Instituto Rosenbusch's return on assets of this year was 0.60442837. Instituto Rosenbusch's return on assets of last year was -0.25271529. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Instituto Rosenbusch's current Net Income (TTM) was 999. Instituto Rosenbusch's current Cash Flow from Operations (TTM) was 665. ==> 665 <= 999 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=562.345/3575.0868
=0.15729548

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=206.369/1775.6528
=0.11622148

Instituto Rosenbusch's gearing of this year was 0.15729548. Instituto Rosenbusch's gearing of last year was 0.11622148. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=5154.844/2103.757
=2.45030391

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=1260.588/862.709
=1.46119723

Instituto Rosenbusch's current ratio of this year was 2.45030391. Instituto Rosenbusch's current ratio of last year was 1.46119723. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Instituto Rosenbusch's number of shares in issue this year was 42.589. Instituto Rosenbusch's number of shares in issue last year was 42.589. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=2295.297/5174.863
=0.44354739

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1732.705/4041.483
=0.42873

Instituto Rosenbusch's gross margin of this year was 0.44354739. Instituto Rosenbusch's gross margin of last year was 0.42873. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=5174.863/1652.525
=3.13148848

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=4041.483/848.619
=4.76242342

Instituto Rosenbusch's asset turnover of this year was 3.13148848. Instituto Rosenbusch's asset turnover of last year was 4.76242342. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+0+0+1+1+1+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Instituto Rosenbusch has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Instituto Rosenbusch  (BUE:ROSE) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Instituto Rosenbusch Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Instituto Rosenbusch's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Instituto Rosenbusch (BUE:ROSE) Business Description

Traded in Other Exchanges
N/A
Address
Hipolito Yrigoyen 1628, Buenos Aires, ARG, C1089AAF
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.